Crohn's disease - infliximab (TA40) (replaced by TA187)
The clinical effectiveness and cost effectiveness of infliximab for Crohn's Disease
This guidance has been replaced by TA187 Crohn's disease - infliximab (review) and adalimumab (review of TA40)
- None found
This page was last updated: 20 December 2011
Implementation tools and resources
- None available
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.